Abstract

Chlamydia trachomatis remains one of the few major human pathogens for which there is no transformation system. C. trachomatis has a unique obligate intracellular developmental cycle. The extracellular infectious elementary body (EB) is an infectious, electron-dense structure that, following host cell infection, differentiates into a non-infectious replicative form known as a reticulate body (RB). Host cells infected by C. trachomatis that are treated with penicillin are not lysed because this antibiotic prevents the maturation of RBs into EBs. Instead the RBs fail to divide although DNA replication continues. We have exploited these observations to develop a transformation protocol based on expression of β-lactamase that utilizes rescue from the penicillin-induced phenotype. We constructed a vector which carries both the chlamydial endogenous plasmid and an E.coli plasmid origin of replication so that it can shuttle between these two bacterial recipients. The vector, when introduced into C. trachomatis L2 under selection conditions, cures the endogenous chlamydial plasmid. We have shown that foreign promoters operate in vivo in C. trachomatis and that active β-lactamase and chloramphenicol acetyl transferase are expressed. To demonstrate the technology we have isolated chlamydial transformants that express the green fluorescent protein (GFP). As proof of principle, we have shown that manipulation of chlamydial biochemistry is possible by transformation of a plasmid-free C. trachomatis recipient strain. The acquisition of the plasmid restores the ability of the plasmid-free C. trachomatis to synthesise and accumulate glycogen within inclusions. These findings pave the way for a comprehensive genetic study on chlamydial gene function that has hitherto not been possible. Application of this technology avoids the use of therapeutic antibiotics and therefore the procedures do not require high level containment and will allow the analysis of genome function by complementation.

Highlights

  • C. trachomatis is a major human pathogen with a unique intracellular developmental cycle [1,2]

  • We have proven the role of the chlamydial plasmid in glycogen biosynthesis by re-introducing the plasmid into a C. trachomatis strain that is plasmid-free (C. trachomatis L2 (25667R)) [15]

  • We have developed a simple and reproducible genetic transformation protocol for C. trachomatis based on calcium chloride treatment of elementary body (EB)

Read more

Summary

Introduction

C. trachomatis is a major human pathogen with a unique intracellular developmental cycle [1,2] This cycle begins when the extracellular, infectious form of the microorganism, the EB, binds to susceptible host cells [3,4]. Despite the availability of the plasmid as a potential vector, the development of a simple robust genetic transformation system for the chlamydiae has remained a significant challenge [11]. The demand for such a system is evidenced by the recent development of a means to mutate the C. trachomatis chromosome [12] but to reach its full potential this requires a complementary gene transfer system. This plasmidcured strain and the naturally occurring plasmid-free strains do

Author Summary
Conclusions
Materials and Methods
Preparation of EBs for transformation
Transformation is performed as follows
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call